PPA
IGMS

Parametric Portfolio Associates’s IGM Biosciences IGMS Stock Holding History

Parametric Portfolio Associates’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,398
Closed -$355K – 3667
2021
Q3 		$355K Buy
5,398
+378
+8% +$28.9K ﹤0.01% 3235
2021
Q2 		$418K Sell
5,020
-305
-6% -$22.6K ﹤0.01% 3156
2021
Q1 		$408K Buy
+5,325
New +$485K ﹤0.01% 3590

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Parametric Portfolio Associates's IGMS Position: Q4 2021 in Review

Parametric Portfolio Associates sold out of IGM Biosciences (IGMS) in Q4 2021, closing a stake of 5,398 shares — an estimated $355K sold.

Parametric Portfolio Associates first reported a position in IGMS in Q1 2021 and held it in 3 quarters. The position peaked at $418K in Q2 2021. 87 funds tracked by Wall St. Rank hold IGMS as of Q4 2021.

  • Parametric Portfolio Associates reported no remaining IGM Biosciences position as of Q4 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 5,398 IGM Biosciences shares in Q4 2021, an estimated $355K.
  • Parametric Portfolio Associates first reported a position in IGM Biosciences in Q1 2021 and held it in 3 quarters.
  • Parametric Portfolio Associates's IGM Biosciences position peaked at $418K in Q2 2021.
  • 87 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2021.

Based on Parametric Portfolio Associates's 13F filing for Q4 2021, filed 15 Feb 2022.